ArticlePreventive medicine reports2026
Development and implementation of a rapid surveillance system for tobacco product retail availability in six U.S. sites.
Article in Preventive medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Accelerating tobacco regulatory science in the United States: The center for rapid surveillance of tobacco.Preventive medicine reports · 2026Article
- Rapid tobacco surveillance among young people in six states: Methods and findings from the Center for Rapid Surveillance of Tobacco Youth and Young Adult Cohort.Preventive medicine reports · 2026Article
- Pushing the US nicotine pouch market: insights from Zyn's free can campaign in September 2025.Tobacco control · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Objective: The tobacco/nicotine retail landscape is continuously evolving. Monitoring product availability is critical to identifying industry response to regulatory action and shifts in consumer behavior and patterns of use. Methods: Beginning January 2024, a rapid retail surveillance system was implemented in brick-and-mortar retailers across six U.S. sentinel sites (California, Kentucky, New Jersey, North Carolina, Ohio, Vermont) with diverse policy environments and tobacco use patterns. At each site, biannual audits were conducted in approximately 60 retailers. Between January 2024 and May 2025, audits were staggered across months and used a standardized Qualtrics-based tool to document tobacco/nicotine product availability, including flavors, brands, and novel products. Results: Nicotine pouch availability increased from 71.6 % to 81.3 % across waves. Cigarillos and cigarettes remained consistently available in 90 % of retailers, while e-cigarettes were found in ∼75 %. Flavored products were available across categories. The number of unique nicotine pouch brands increased over time, with variation by retailer type and site. Conclusions: Rapid surveillance enables timely detection of market trends and potential policy non-compliance. Continued data collection and integration with other surveillance tools will enhance tobacco control monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.